Methods of selecting compstatin mimetics
US10407466B2 · kind B2 · utility
10Cited by
54References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2017 |
| Grant date | Sep 10, 2019 |
| Priority date | — |
| Expiry date | Jan 6, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features the use of compstatin and complement inhibiting analogs thereof for treating and/or preventing age related macular degeneration and other conditions involving macular degeneration, choroidal neovascularization, and/or retinal neovascularization. The invention also provides compositions comprising compstatin or a complement inhibiting analog thereof and a second therapeutic agent. The invention also provides compositions comprising compstatin or a complement inhibiting analog thereof and a gel-forming material, e.g., soluble collagen, and methods of administering the compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.